Johnson & Johnson

Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace innovation—bringing ideas, products and services to life to advance the health and well-being of people around the world. We believe in collaboration, and that has led to breakthrough after breakthrough, from medical miracles that have changed lives, to the simple consumer products that make every day a little better.

Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Our Family of Companies comprises:

  • The world’s sixth-largest consumer health company
  • The world’s largest and most diverse medical devices company
  • The world’s sixth-largest biologics company
  • And the world’s fifth-largest pharmaceuticals company

We have more than 265 operating companies in more than 60 countries.

Company Growth (employees)
Type
Public
HQ
New Brunswick, US
Founded
1886
Size (employees)
126,400 (est)
Website
jnj.com
Johnson & Johnson was founded in 1886 and is headquartered in New Brunswick, US

Key People at Johnson & Johnson

Alex Gorsky

Alex Gorsky

CEO
Dominic J. Caruso

Dominic J. Caruso

CFO
Ronald A. Williams

Ronald A. Williams

Independent Director
Michael Sneed

Michael Sneed

VP, Global Corporate Affairs
Peter Fasolo

Peter Fasolo

Executive VP, CHRO
Paul Stoffels

Paul Stoffels

Executive VP & CSO

Johnson & Johnson Office Locations

Johnson & Johnson has an office in New Brunswick
New Brunswick, US (HQ)
One Johnson & Johnson Plaza

Johnson & Johnson Data and Metrics

Johnson & Johnson Financial Metrics

Johnson & Johnson's revenue was reported to be $71.9 b in FY, 2016 which is a 3% increase from the previous period.
Numbers are in $, USD

Revenue (FY, 2016)

71.9 b

Revenue growth (FY, 2015 - FY, 2016), %

3%

Gross profit (FY, 2016)

50.2 b

Gross profit margin (FY, 2016), %

70%

Net income (FY, 2016)

16.5 b

EBIT (FY, 2016)

16.5 b

Market capitalization (26-May-2017)

341.9 b

Closing share price (26-May-2017)

127.5

Cash (31-Dec-2016)

19 b

EV

345.4 b
Johnson & Johnson's current market capitalization is $341.9 b.
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

71.3 b74.3 b70.1 b71.9 b

Revenue growth, %

4%(6%)3%

Cost of goods sold

22.3 b22.7 b21.5 b21.7 b

Gross profit

49 b51.6 b48.5 b50.2 b

Gross profit Margin, %

69%69%69%70%

Sales and marketing expense

21.8 b22 b21.2 b19.9 b

R&D expense

8.2 b8.5 b9 b9.1 b

Operating expense total

30 b30.4 b30.2 b29 b

Depreciation and amortization

4.1 b3.9 b3.7 b3.8 b

EBIT

16.4 b21.6 b19.2 b16.5 b

EBIT margin, %

23%29%27%23%

Interest expense

580 m533 m552 m726 m

Interest income

74 m67 m128 m368 m

Pre tax profit

15.5 b20.6 b19.2 b19.8 b

Income tax expense

1.6 b4.2 b3.8 b3.3 b

Net Income

13.8 b16.3 b15.4 b16.5 b
Numbers are in $, USDY, 2010Y, 2011Y, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

15.8 b19.4 b24.5 b20.9 b14.5 b13.7 b19 b

Inventories

7.9 b8.2 b8.1 b8.1 b

Current Assets

56.4 b59.3 b60.2 b65 b

PP&E

16.7 b16.1 b15.9 b15.9 b

Goodwill

22.8 b21.8 b21.6 b22.8 b

Total Assets

132.7 b131.1 b133.4 b141.2 b

Accounts Payable

6.3 b7.6 b6.7 b6.9 b

Total Debt

13.3 b15.1 b12.9 b22.4 b

Current Liabilities

25.7 b25.1 b27.7 b26.3 b

Retained Earnings

89.5 b97.2 b103.9 b110.6 b

Total Equity

71.2 b70.4 b

Debt to Equity Ratio

0.2 x0.3 x

Debt to Assets Ratio

0.1 x0.1 x0.1 x0.2 x

Financial Leverage

1.9 x2 x
Numbers are in $, USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

13.8 b16.3 b15.4 b16.5 b

Accounts Receivable

(632 m)(247 m)(433 m)(1.1 b)

Inventories

(622 m)(1.1 b)(449 m)(249 m)

Accounts Payable

1.8 b955 m656 m

Cash From Operating Activities

17.4 b18.5 b19.3 b18.8 b

Purchases of PP&E

(3.6 b)(3.7 b)(3.5 b)(3.2 b)

Cash From Investing Activities

(5.1 b)(12.3 b)(7.7 b)(4.8 b)

Cash From Financing Activities

(6.1 b)(12.3 b)(10.8 b)(8.6 b)

Interest Paid

596 m603 m515 m730 m

Income Taxes Paid

3.2 b3.5 b2.9 b2.8 b
Numbers are in $, USDY, 2016

EV/EBIT

20.9 x

EV/CFO

18.4 x

Revenue/Employee

566.7 k

Debt/Equity

0.3 x

Debt/Assets

0.2 x

Financial Leverage

2 x

Johnson & Johnson Operating Metrics

FY, 2014FY, 2015FY, 2016

Discovery Projects

100150B

Facilities

121119

Drugs Approved by FDA

2A

Johnson & Johnson Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
Actelion PharmaceuticalsJanuary 26, 2017$30 b
Abott Medical OpticsSeptember 16, 2016$4.3 b
Vogue InternationalJune 02, 2016$3.3 b
Novira TherapeuticsNovember 08, 2015
XO1March 20, 2015
Alios BioPharmaSeptember 30, 2014$1.8 b
Aragon PharmaceuticalsJune 17, 2013$1 b

Johnson & Johnson Market Value History

Johnson & Johnson Revenue Breakdown

Johnson & Johnson Median Salaries

Source: 32 public H-1B filings from Johnson & Johnson

Johnson & Johnson Online and Social Media Presence

Johnson & Johnson Company Life and Culture

You may also be interested in